Modulation of Fas-Ligand (Fas-L) on human microglial cells: An in vitro study

Journal of Neuroimmunology

Volumn 105, Issue 2, 2000, Pages 109-114

  Frigerio, S ^a   Silei, V ^b   Ciusani, E ^a   Massa, G ^a   Lauro, G M ^b   Salmaggi, A ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

Author keywords

Apoptosis; Fas Ligand; Microglia

Indexed keywords

FAS LIGAND; GAMMA INTERFERON; INTERFERON BETA SERINE;

APOPTOSIS; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; FETUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; IN VITRO STUDY; LEUKEMIA CELL LINE; MICROGLIA; PRIORITY JOURNAL; WESTERN BLOTTING;

CELLS, CULTURED; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERFERON-BETA; MEMBRANE GLYCOPROTEINS; MICROGLIA; RNA, MESSENGER;

EID: 0034717889     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00227-1     Document Type: Article

References (14)

1. Bonetti B., Raine C.S. Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42:1997;74-84.
2. Chulhee C., Joo Young P., Jeonggi L., Jung-Hee L., Eui-Cheol S., Young Soo A., Chul-Hoon K., Joo-Deuk K., Il Saing C., In-Hong C. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6 TNF-α or IFN-γ J. Immunol. 162:1999;1889-1895.
3. Cohen J.J. Apoptosis. Immunol. Today. 14:1993;126-130.
4. D'Souza D.S., Bonetti B., Vijayabalan B., Cashman N.R., Barker P.A., Troutt A.B., Raine C.S., Antel J.P. Multiple sclerosis Fas signaling in oligodendrocytes cell death. J. Exp. Med. 184:1996;2361-2370.
5. Di Pucchio T., Ennas M.G., Presta M., Lauro G.M. Basic fibroblast growth factor modulates in vitro differentiation of human fetal microglia. NeuroReport. 7:1996;2813-2817.
6. Dowling P., Shang G., Raval S., Menonna J., Cook S., Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184:1996;1513-1518.
7. Fukunaga R.W., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediate apoptosis. Nature. 356:1992;314-317.
8. Hall G.E., Wing M.G., Compston D.A.S., Scolding N.J. Interferon regulates the immunomodulatory activity of neonatal rodent microglia. J. Neuroimmunol. 72:1997;11-19.
9. Kang S., Schneider D.B., Lin Z., Hanahan D., Dichek D.A., Stock P.G., Baekkeskov S., Baekkeskov S. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat. Med. 3:(7):1997;738-743.
10. Lauro G.M., Babiloni D., Buttarelli F.R., Starace G., Cocchia D., Ennas M.G., Sogos V., Gremo F. Human microglia cultures: a powerful model to study their origin and immunoreactive capacity. Int. J. Dev. Neurosci. 13:1995;739-752.
11. McGahon A.J., Martin S.J., Bissonette R.P., Mahboubi A., Shi Y., Mogil R.J., Nishioka W.K., Green D.R. The end of the (cell) line: methods for the study of apoptosis in vitro. Methods in Cell Biology. 46:1995;153-185.
12. Norohona A., Toscas S., Jensen M.A. Interferon beta decreases T cell activation and interferon-gamma production in multiple sclerosis. J. Neuroimmunol. 46:1993;145-154.
13. White C.A., McCombe P.A., Pender M.P. The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 82:(1):1998;47-55.
14. Mincheff M., Loukinov D., Zoubak S., Hammet M., Meryman H. Fas and Fas Ligand expression on human peripheral blood leukocytes. Vox Sang. 74:1998;113-121.